Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ANSI certification expected soon

This article was originally published in The Gold Sheet

Executive Summary

Irwin Silverstein, vice-president and chief executive officer of International Pharmaceutical Excipients Auditing Inc., said that he expects the organization's third-party audit program of excipient suppliers to be certified by the American National Standards Institute by "the end of the first quarter of this year." He expects certification to ensure greater legitimacy - and acceptance - of IPEA's audit program among the pharmaceutical industry and FDA. He noted that "we're starting to gain more acceptance" with respect to third-party review of excipient suppliers. "2009 was a good year for the third-party certification program, it was a successful year." Silverstein further noted that "I think the agency sees the handwriting on the wall" with respect to third-party certification. "We think FDA will accept ANSI accreditation. The agency is one of the final arbiters. If ANSI says we have a good system, so should FDA." IPEA provides third-party audits of excipient manufacturers and auditor training and is an independent subsidiary of IPEC-Americas

Latest Headlines
See All
UsernamePublicRestriction

Register

PS000450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel